Literature DB >> 8705859

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

K Huygen1, J Content, O Denis, D L Montgomery, A M Yawman, R R Deck, C M DeWitt, I M Orme, S Baldwin, C D'Souza, A Drowart, E Lozes, P Vandenbussche, J P Van Vooren, M A Liu, J B Ulmer.   

Abstract

Tuberculosis is the most widespread and lethal infectious disease affecting humans. Immunization of mice with plasmid DNA constructs encoding one of the secreted components of Mycobacterium tuberculosis, antigen 85 (Ag85), induced substantial humoral and cell-mediated immune responses and conferred significant protection against challenge with live M. tuberculosis and M. bovis bacille Calmette-Guérin (BCG). These results indicate that immunization with DNA encoding a mycobacterial antigen provides an efficient and simple method for generating protective immunity and that this technique may be useful for defining the protective antigens of M. tuberculosis, leading to the development of a more effective vaccine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705859     DOI: 10.1038/nm0896-893

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  168 in total

1.  Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

Authors:  A Weinrich Olsen; L A van Pinxteren; L Meng Okkels; P Birk Rasmussen; P Andersen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Authors:  J Turner; E R Rhoades; M Keen; J T Belisle; A A Frank; I M Orme
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Current and Future Use of Vaccines for Viral and Bacterial Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

5.  Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

Authors:  K Pehler; K M Brasky; T M Butler; R Attanasio
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

6.  Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.

Authors:  E Martin; J A Triccas; A T Kamath; N Winter; W J Britton
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

7.  Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

Authors:  Helen McShane; Shahriar Behboudi; Nilu Goonetilleke; Roger Brookes; Adrian V S Hill
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.

Authors:  A Jepson; A Fowler; W Banya; M Singh; S Bennett; H Whittle; A V Hill
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

10.  Incorporation of antigens into viral capsids augments immunogenicity of adeno-associated virus vector-based vaccines.

Authors:  Jan Rybniker; Angela Nowag; Hanna Janicki; Kai Demant; Pia Hartmann; Hildegard Büning
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.